The study authors examined the mortality risk and life expectancy of 484,916 people (average age was 40.3 years old, with ...

Emily Kramer-Golinkoff can’t get enough oxygen with each breath. Advanced cystic fibrosis makes even simple things like ...

Idiopathic pulmonary fibrosis (IPF) occurs when scar tissue builds up in the lungs, causing the walls to stiffen and making ...

Emphasizing its advanced cardiac care capabilities, Apollo Hospitals Navi Mumbai (AHNM), successfully treated two cases – one of pulmonary embolism and another of myocardial infarction – saving the ...

Hantavirus, a respiratory virus spread by rodents, has been in the news recently. Experts explain what you need to know about ...

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

The VASST trial was first published in 2008 and has spawned 16 years of analysis and debate. Aaron Holley, MD, has vacillated ...

Brensocatib significantly reduced the rate of pulmonary exacerbations and slowed lung function decline in patients with ...

Leading specialists in pulmonology have formed Healio Pulmonology’s Peer Perspective Board to help guide coverage and provide ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...